GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Citius Oncology Inc (NAS:CTOR) » Definitions » Price-to-Tangible-Book

CTOR (Citius Oncology) Price-to-Tangible-Book : (As of May. 08, 2025)


View and export this data going back to 2024. Start your Free Trial

What is Citius Oncology Price-to-Tangible-Book?

As of today (2025-05-08), Citius Oncology's share price is $0.847. Citius Oncology's Tangible Book per Share of Sep. 2024 for the quarter that ended in Sep. 2024 was $-0.38. Hence, Citius Oncology's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for Citius Oncology's Price-to-Tangible-Book or its related term are showing as below:

CTOR's Price-to-Tangible-Book is not ranked *
in the Drug Manufacturers industry.
Industry Median: 2.23
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Citius Oncology's share price is $0.847. Citius Oncology's Book Value per Sharefor the quarter that ended in Sep. 2024 was $0.65. Hence, Citius Oncology's P/B Ratio of today is 1.31.

Citius Oncology Price-to-Tangible-Book Historical Data

The historical data trend for Citius Oncology's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Citius Oncology Price-to-Tangible-Book Chart

Citius Oncology Annual Data
Trend Sep22 Sep23 Sep24
Price-to-Tangible-Book
- - -

Citius Oncology Semi-Annual Data
Sep22 Sep23 Sep24
Price-to-Tangible-Book - - -

Competitive Comparison of Citius Oncology's Price-to-Tangible-Book

For the Drug Manufacturers - Specialty & Generic subindustry, Citius Oncology's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Citius Oncology's Price-to-Tangible-Book Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Citius Oncology's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Citius Oncology's Price-to-Tangible-Book falls into.


;
;

Citius Oncology Price-to-Tangible-Book Calculation

Citius Oncology's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Sep. 2024 )
=0.847/-0.381
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price to Tangible Book=Market Cap/Tangible Equity
=Market Cap/(Total Stockholders Equity-Preferred Stock-Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Citius Oncology Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Citius Oncology's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Citius Oncology Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Citius Oncology Inc (NAS:CTOR) » Definitions » Price-to-Tangible-Book
Comparable Companies
ETST ASRT MRMD RMTI SCYX CPIX INCR SXTC RSCI INIS ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD NSE:DIVISLAB HKSE:03692 XSWX:SDZ XTAE:TEVA
Traded in Other Exchanges
N/A
Address
11 Commerce Drive, First Floor, Cranford, NY, USA, 07016
Website
https://www.citiusonc.com
Citius Oncology Inc is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products targeting unmet needs with a focus on oncology products. In addition, Citius completed enrollment in its Phase 2b trial of CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids.